logo conference-reports

Conference Reports

При финансовой поддержке logo MSD Oncology

ESMO 2019 — Extensive small cell lung cancer: immunotherapy benefits some patients, but biomarkers not found

Newly published analyses confirm modest benefits, but PD-L1 found to have no influence.